Takuya Fushimi

845 total citations
23 papers, 299 citations indexed

About

Takuya Fushimi is a scholar working on Molecular Biology, Clinical Biochemistry and Genetics. According to data from OpenAlex, Takuya Fushimi has authored 23 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Clinical Biochemistry and 4 papers in Genetics. Recurrent topics in Takuya Fushimi's work include Mitochondrial Function and Pathology (16 papers), Metabolism and Genetic Disorders (13 papers) and ATP Synthase and ATPases Research (7 papers). Takuya Fushimi is often cited by papers focused on Mitochondrial Function and Pathology (16 papers), Metabolism and Genetic Disorders (13 papers) and ATP Synthase and ATPases Research (7 papers). Takuya Fushimi collaborates with scholars based in Japan, Italy and Switzerland. Takuya Fushimi's co-authors include Kei Murayama, Akira Ohtake, Yasushi Okazaki, Yoshihito Kishita, Masaru Shimura, Keiko Ichimoto, Ayako Matsunaga, Masakazu Kohda, Makiko Tajika and Tomoko Tsuruoka and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Medical Genetics.

In The Last Decade

Takuya Fushimi

20 papers receiving 298 citations

Peers

Takuya Fushimi
John W. Yarham United Kingdom
Colleen Muraresku United States
Dmitriy M. Niyazov United States
Kate Craig United Kingdom
Takuya Fushimi
Citations per year, relative to Takuya Fushimi Takuya Fushimi (= 1×) peers Ayako Matsunaga

Countries citing papers authored by Takuya Fushimi

Since Specialization
Citations

This map shows the geographic impact of Takuya Fushimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuya Fushimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuya Fushimi more than expected).

Fields of papers citing papers by Takuya Fushimi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuya Fushimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuya Fushimi. The network helps show where Takuya Fushimi may publish in the future.

Co-authorship network of co-authors of Takuya Fushimi

This figure shows the co-authorship network connecting the top 25 collaborators of Takuya Fushimi. A scholar is included among the top collaborators of Takuya Fushimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuya Fushimi. Takuya Fushimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yokota, Kazuhiro, Taro Yamazaki, Takuya Fushimi, et al.. (2025). Carbamoyl phosphate synthetase 1 deficiency manifested in an adult treated with prednisone for polymyositis, and cured by live-donor liver transplantation. Molecular Genetics and Metabolism Reports. 43. 101200–101200.
2.
Yatsuka, Yukiko, Akira Hasegawa, Takeya Kasukawa, et al.. (2025). Successful Diagnosis of Sengers Syndrome Using a Comprehensive Genomic Analysis. Molecular Genetics & Genomic Medicine. 13(1). e70048–e70048.
3.
Ozaki, Kokoro, Yukiko Yatsuka, Yoshinobu Oyazato, et al.. (2024). Biallelic GGGCC repeat expansion leading to NAXE-related mitochondrial encephalopathy. npj Genomic Medicine. 9(1). 48–48. 1 indexed citations
4.
Kishita, Yoshihito, Ayumu Sugiura, Tetsuro Matsuhashi, et al.. (2023). Strategic validation of variants of uncertain significance in ECHS1 genetic testing. Journal of Medical Genetics. 60(10). 1006–1015. 2 indexed citations
5.
Kishita, Yoshihito, Mina Nakama, Hideo Sasai, et al.. (2023). Novel ITPA variants identified by whole genome sequencing and RNA sequencing. Journal of Human Genetics. 68(9). 649–652. 2 indexed citations
6.
Tajika, Makiko, Tetsuro Matsuhashi, Masaru Shimura, et al.. (2022). A Japanese single-center experience of the efficacy and safety of asfotase alfa in pediatric-onset hypophosphatasia. Orphanet Journal of Rare Diseases. 17(1). 78–78. 6 indexed citations
7.
Tsuruoka, Tomoko, Masaru Shimura, Makiko Tajika, et al.. (2022). Severe spinal cord hypoplasia due to a novel ATAD3A compound heterozygous deletion. Molecular Genetics and Metabolism Reports. 33. 100912–100912. 4 indexed citations
9.
Shimura, Masaru, Taro Yamazaki, Hiroko Harashima, et al.. (2021). Prenatal diagnosis of severe mitochondrial diseases caused by nuclear gene defects: a study in Japan. Scientific Reports. 11(1). 3531–3531. 1 indexed citations
10.
Shimura, Masaru, Tetsuro Matsuhashi, Takuya Fushimi, et al.. (2021). Development of Leigh syndrome with a high probability of cardiac manifestations in infantile-onset patients with m.14453G > A. Mitochondrion. 63. 1–8. 7 indexed citations
11.
Kishita, Yoshihito, Kaori Ishikawa, Kazuto Nakada, et al.. (2021). A high mutation load of m.14597A>G in MT-ND6 causes Leigh syndrome. Scientific Reports. 11(1). 11123–11123. 12 indexed citations
12.
Tsuruoka, Tomoko, Masaru Shimura, Makiko Tajika, et al.. (2021). Neonatal-onset mitochondrial disease: clinical features, molecular diagnosis and prognosis. Archives of Disease in Childhood Fetal & Neonatal. 107(3). 329–334. 10 indexed citations
13.
Shimura, Masaru, Minako Ogawa‐Tominaga, Tetsuro Matsuhashi, et al.. (2020). Therapeutic effect of N-carbamylglutamate in CPS1 deficiency. Molecular Genetics and Metabolism Reports. 24. 100622–100622. 11 indexed citations
14.
Ichimoto, Keiko, Tomoo Fujisawa, Takuya Fushimi, et al.. (2020). Two cases of a non-progressive hepatic form of glycogen storage disease type IV with atypical liver pathology. Molecular Genetics and Metabolism Reports. 24. 100601–100601. 4 indexed citations
15.
Shimura, Masaru, Takuya Fushimi, Keiko Ichimoto, et al.. (2020). Efficacy of bezafibrate in two patients with mitochondrial trifunctional protein deficiency. Molecular Genetics and Metabolism Reports. 24. 100610–100610. 7 indexed citations
16.
Hirono, Keiichi, Fukiko Ichida, Minako Ogawa‐Tominaga, et al.. (2019). Mitochondrial complex deficiency by novel compound heterozygous TMEM 70 variants and correlation with developmental delay, undescended testicle, and left ventricular noncompaction in a Japanese patient: A case report. SHILAP Revista de lepidopterología. 7(3). 553–557. 13 indexed citations
17.
Kishita, Yoshihito, Masakazu Kohda, Yosuke Mizuno, et al.. (2019). Cardiomyopathy in children with mitochondrial disease: Prognosis and genetic background. International Journal of Cardiology. 279. 115–121. 33 indexed citations
18.
Borna, Nurun Nahar, Yoshihito Kishita, Masakazu Kohda, et al.. (2019). Mitochondrial ribosomal protein PTCD3 mutations cause oxidative phosphorylation defects with Leigh syndrome. Neurogenetics. 20(1). 9–25. 44 indexed citations
19.
Shimura, Masaru, Minako Ogawa‐Tominaga, Takuya Fushimi, et al.. (2019). Effects of 5-aminolevulinic acid and sodium ferrous citrate on fibroblasts from individuals with mitochondrial diseases. Scientific Reports. 9(1). 10549–10549. 26 indexed citations
20.
Ogawa, Erika, Masaru Shimura, Takuya Fushimi, et al.. (2017). Clinical validity of biochemical and molecular analysis in diagnosing Leigh syndrome: a study of 106 Japanese patients. Journal of Inherited Metabolic Disease. 40(5). 685–693. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026